Reynolds Consumer Products' flat ROCE and capital employed trend over five years indicates a mature, stable business not re-investing earnings, possibly explaining modest stock returns. It may not be a promising multi-bagger stock candidate.
Despite inflation, household product stocks remain resilient, with an average 7.1% increase since the last earnings. Clorox surpassed analyst estimates but had the slowest revenue growth, while WD-40 had the fastest among peers.
Despite challenges like changing consumer behavior, high inflation, and extreme weather, household product stocks have remained resilient. Central Garden & Pet, Clorox, Spectrum Brands, Colgate-Palmolive, and Reynolds reported strong quarters.
The report criticises Reynolds Consumer Products for its diminishing returns and stagnated shareholder return over the last three years. Assertions were also made about longer-term investments not currently helping the bottom line.
$Lumen Technologies (LUMN.US)$ – Shares of Lumen Technologies jumped 4.8% as investors look to buy back into the company after it shed nearly 30% when it reported disappointing earnings results earlier in the month. $美敦力 (MDT.US)$ – Shares of the health-care technology company shed 4% after it reported results of a study on hypertension that showed a device it created only helped reduce blood pressure slightly more than medications. $Robinhood (HOOD.US)$ – Shares of trading platform Robinh...
NNVC personally I don't care for them but you have to respect their gains with that said don't forget your stop loss $Co-diagnostics (CODX.US)$ $伊諾維奧製藥 (INO.US)$closing of offering soon $Vaxart (VXRT.US)$I really like this one I've had it since. 0.89 and believe that it will soon hit 2.25-2.50
Reynolds Consumer Products股票討論
– Shares of Lumen Technologies jumped 4.8% as investors look to buy back into the company after it shed nearly 30% when it reported disappointing earnings results earlier in the month.
$美敦力 (MDT.US)$
– Shares of the health-care technology company shed 4% after it reported results of a study on hypertension that showed a device it created only helped reduce blood pressure slightly more than medications.
$Robinhood (HOOD.US)$
– Shares of trading platform Robinh...
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $艾斯本科技 (AZPN.US)$ +5.4%, $艾倫建材 (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...
• $博思艾倫諮詢公司 (BAH.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $102 (from $83)
• $哈門那 (HUM.US)$: UBS Upgrades to Buy from Neutral - PT $520 (from $486)
• $JB亨特運輸服務 (JBHT.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $230 (from $210)
Downgrades
• $JB亨特運輸服務 (JBHT.US)$: B.Riley Downgrades to Neutral from Buy - PT $33 (from $62)
• $CACI國際 (CACI.US)$: Goldman Sachs Downgrad...
• $Customers Bancorp (CUBI.US)$ : KBW Upgrades to Outperform from Market Perform - PT $80 (from $72)
• $飛塔信息 (FTNT.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $395 (from $364)
• $Hoegh LNG (HMLP.US)$ : Stifel Upgrades to Buy from Hold - PT $9.50 (from $8)
• $Randolph Bancorp (RNDB.US)$ : Compass Point Upgrades to Buy from Neutral - PT $27 (from $23)
• $SiteOne Landscape Supply (SITE.US)$ : UBS Upgrades to Neutral from Sell - PT $165 (fr...
$Co-diagnostics (CODX.US)$
$伊諾維奧製藥 (INO.US)$ closing of offering soon
$Vaxart (VXRT.US)$ I really like this one I've had it since. 0.89 and believe that it will soon hit 2.25-2.50
暫無評論